Stock listing

TASE:XTLB XTL Biopharmaceuticals Ltd. מניה‎

Home listing (TASE) of XTL Biopharmaceuticals Ltd.

Follow XTL Biopharmaceuticals Ltd. into a list and get an email when it puts out news.

Share price · TASE:XTLB

1.40 ILA (agorot) 0.00 (0.0%)

Close on Oct 29, 2026

Past year -67.4% · daily closes, Oct 29, 2025 – Oct 29, 2026, adjusted for splits
Day range
1.40 – 1.50 ILA (agorot)Oct 29, 2026
Volume
458,200 sharesOct 29, 2026
Market cap
13.76M ILSAt the close on Oct 29, 2026 · price × 983.0M shares outstanding
52-week range
1.40 – 4.40 ILA (agorot)Lowest and highest trades, Oct 30, 2025 – Oct 29, 2026
Traded on an average day
16,612 ILSMedian day 458,672 shares · 6 days with no trades · last 3 months, Jul 29, 2026 – Oct 29, 2026
XTL Biopharmaceuticals Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
TASE:XTLB · Home1.40 ILA (agorot)0.00 (0.0%)458,2001.401.501.401.40Close on Oct 29, 2026
NASDAQ:XTLB$1.81 USD-0.21 (-10.4%)2,211$1.78$1.81$1.75$2.02Close on Oct 27, 2026

Daily closes

Last 3 months, Jul 29, 2026 – Oct 29, 2026 · TASE:XTLB · ILA (agorot), adjusted for splits

DayCloseChange%OpenHighLowVolume
1.400.000.0%1.401.501.40458,200
1.40-0.10-6.7%1.401.401.401,796,138
1.50+0.10+7.1%1.501.501.5021,000
1.40-0.10-6.7%1.501.601.403,159,216
1.500.000.0%1.501.501.5079,600
1.50-0.10-6.3%1.601.601.50103,766
1.60+0.10+6.7%1.501.601.50443,736
1.500.000.0%1.501.501.50340,500
1.50-0.10-6.3%1.601.601.501,537,736
1.600.000.0%1.601.601.6056,073
1.600.000.0%1.601.601.6073
1.600.000.0%1.601.601.60225,000
1.60+0.10+6.7%1.601.601.600
1.50-0.10-6.3%1.601.701.501,285,548
1.60-0.20-11.1%1.701.801.603,520,742
1.800.000.0%1.801.801.702,228,534
1.800.000.0%1.901.901.80927,528
1.800.000.0%1.801.901.80776,000
1.80-0.10-5.3%1.801.801.80459,143
1.900.000.0%1.901.901.80527
1.900.000.0%1.901.901.900
1.90+0.10+5.6%1.802.001.80120,000
1.800.000.0%1.801.801.800
1.800.000.0%1.801.901.80625,625
1.80-0.10-5.3%1.901.901.80679,452
1.90+0.10+5.6%1.901.901.90252,631
1.800.000.0%1.801.801.800
1.80-0.10-5.3%1.801.801.80119,048
1.900.000.0%1.901.901.900
1.90+0.10+5.6%1.901.901.900
1.80-0.10-5.3%1.901.901.80255,855
1.90+0.10+5.6%1.901.901.90465,657
1.80-0.10-5.3%1.901.901.80631,533
1.900.000.0%1.902.001.9032,000
1.900.000.0%1.902.001.80683,470
1.900.000.0%1.901.901.90368,420
1.900.000.0%1.901.901.90158,095
1.900.000.0%1.901.901.9052,832
1.900.000.0%2.002.001.901,240,183
1.90-0.10-5.0%1.901.901.901,309,052
2.000.000.0%2.002.001.90538,500
2.000.000.0%2.002.002.00261,500
2.00-0.10-4.8%2.102.102.00588,800
2.10+0.10+5.0%2.102.102.10664,406
2.000.000.0%2.102.102.009,613,664
2.000.000.0%1.902.001.90311,616
2.00+0.10+5.3%1.902.001.804,809,641
1.90-0.10-5.0%2.002.001.90188,977
2.00-0.10-4.8%2.002.001.90965,254
2.100.000.0%2.102.102.10190,476
2.10-0.10-4.5%2.202.202.001,268,181
2.20+0.10+4.8%2.202.202.101,505,700
2.10+0.20+10.5%2.002.202.004,330,047
1.90-0.10-5.0%2.102.101.90778,008
2.000.000.0%2.102.102.00664,014
2.000.000.0%2.002.002.00771,815
2.000.000.0%2.002.002.00125,200
2.000.000.0%2.002.002.00936,801
2.000.000.0%2.002.002.00500,000
2.00-0.10-4.8%2.002.002.00206,000
Ticker
TASE:XTLB
Asset type
Stock
Exchange
TASE
Currency
ILA

What changed lately

Latest news

XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies

Apr 29, 2026

Closed 2.60 (+36.8%) on Apr 29, 2026

XTL Biopharmaceuticals Announces ADS Ratio Change

Mar 20, 2026

Closed 2.00 (-4.8%) on Mar 23, 2026

XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing

Feb 27, 2026

Closed 2.00 (-9.1%) on Mar 2, 2026

XTL Update on Recent Developments

Jan 29, 2026

Closed 2.80 (+7.7%) on Jan 30, 2026

XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency

Jan 23, 2026

Closed 2.90 (-6.5%) on Jan 26, 2026

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

Jan 13, 2026

Closed 2.70 (-22.9%) on Jan 14, 2026

XTL Biopharmaceuticals Acquires 85% of Beyond Air’s Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

Jan 13, 2026

Closed 3.50 (+52.2%) on Jan 13, 2026

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Dec 24, 2025

Closed 2.60 (-3.7%) on Dec 25, 2025

XTL Names Mr. Noam Band as its New Chief Executive Officer

Apr 7, 2025

All XTL Biopharmaceuticals Ltd. news

Decks

XTL Biopharmaceuticals Ltd. on 6ix

News releases
8 in the last 12 months · 9 in all · newest Apr 29, 2026 · oldest 2025
Decks
9 decks · latest Nov 8, 2018

Where XTL Biopharmaceuticals Ltd. is listed

ListingExchangeCountryCurrency
TASE:XTLB · Home listing · This pageTASEIsraelILA
NASDAQ:XTLBNASDAQUnited StatesUSD
BOATS:XTLBBOATSUnited StatesUSD
gettex:HHB0gettexGermanyEUR
Munich:HHB0MunichGermanyEUR
Frankfurt:HHB0FrankfurtGermanyEUR
Lang & Schwarz:A41X7JLang & SchwarzGermanyEUR
LS Exchange:A41X7JLS ExchangeGermanyEUR
Stuttgart:HHB0StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about XTL Biopharmaceuticals Ltd.